ENTX Entera Bio Corp: Accounting Value per Share

Entera Bio Ltd. (ENTX) operates in the high-risk segment of developing oral hormone analogs without current sales. The change in BVPS reflects the dynamics of net equity per share, where this metric equals 0.15. Value growth is based on scaling the peptide delivery platform for osteoporosis, while potential is bolstered by B2B partnerships aimed at replacing injections with tablets.

Entera Bio Corp (ENTX): Share Book Value from 07/04/2022 to 10/27/2026

Entera Bio Ltd - analytical breakdowns and key metrics (ENTX)

- price and consensus price forecast:

Stock Quotes Entera Bio Corp|ENTX - Analyst Forecast Prices

- market capitalization data:

Market Valuation Entera Bio Ltd.|ENTX - Business Value

- book capitalization data:

Net Assets per Single Share Entera Bio|ENTX - Net Asset Value|Market Capitalization to Book Value Ratio enterabio.com|ENTX - Aggregate Asset Value

- debt and liquidity data:

Total Debt to Capital Entera Bio Ltd.|ENTX - Long-Term Debt to Capital|Short-Term Debt to Equity Entera Bio Corp|ENTX - Aggregate Debt Obligations|Debt to Book Capitalization Ratio Entera Bio Ltd.

Fundamental company valuation:enterabio.com - ENTX

Manufactured products of Entera Bio Corp

Book value per share reflects the portion of equity attributable to a single security, allowing for the determination of the company's intrinsic value regardless of market volatility. By analyzing changes in BVPS, an investor can see how the capitalization of intellectual property rights for the ProNeura platform and patent protection sustain the fundamental stability of Entera Bio Ltd. (ENTX) in the face of generic competition.

Competitors of Entera Bio Ltd. (ENTX)

Accounting Value per Share Haleon Group HLN|Kenvue Health (KVUE) - Book Price of a Share|Accounting Value per Share Verona Pharma plc|MENS (jyongbio.com) - Equity per Share|Net Assets per Single Share Ligand LGND|Share Book Value Amneal Pharmaceuticals, Inc.|Perrigo Company (PRGO) - Book Value per Share|Accounting Value of a Share Alvotech Biopharmaceuticals (ALVO)|Book Value per Share LQDA (Liquidia Corporation)|glpg.com - Book Value per Share|Net Assets per Single Share ANI Pharmaceuticals, Inc. (ANIP)|MNKD: Accounting Value of a Share|AMPH (Amphastar) - Net Assets per Single Share|Pacira Corp (PCRX) - Accounting Value per Share|SPRY (ARS Pharmaceuticals) - Book Value per Share|Book Value per Share theravance.com (TBPH)|Aquestive Therapeutics, Inc. (AQST) - Accounting Value per Share|Accounting Value of a Share SCPH (scpharmaceuticals.com)|TECX: Net Assets per Single Share|TNXP - Net Asset Value per Share|Accounting Value per Share SXT China SXTC|EPRX - Book Price of a Share|Book Value per Share BioHarvest Sciences Inc. BHST|Invizyne Technologies (EXOZ) - Accounting Value of a Share|Book Value per Share ORMP (Oramed)|Net Asset Value per Share HYFT|ABVC BioPharma (ABVC) - Net Assets per Single Share|Accounting Value of a Share cumberlandpharma.com (CPIX)|QNTM: Book Value per Share|FibroGen Inc - Net Asset Value per Share|Telomir Pharma (TELO) - Net Assets per Single Share|Rani Therapeutics (RANI) - Equity per Share|SNYR - Accounting Value per Share|Rallybio (RLYB) - Book Price of a Share|Book Value per Share LEXX (Lexaria Bioscience Corp)|Net Asset Value per Share PULM|Pheton Holdings Ltd (PTHL) - Net Assets per Single Share|Accounting Value of a Share aptorumgroup.com (APM)|Book Value per Share LYRA (Lyra Therapeutics, Inc.)|IBO - Book Value per Share|Accounting Value per Share TNF Pharma (TNFA)|YCBD - Accounting Value of a Share|PainReform Limited (PRFX) - Book Value per Share|Altamira Therapeutics Ltd. (CYTO) - Net Assets per Single Share|LIPO: Book Value per Share|Net Assets per Share OPTN|Pieris Pharmaceuticals, Inc. - Net Assets per Single Share|Net Asset Value per Share Procaps Group PROC|Accounting Value per Share Petros|Qilian International Corp - Accounting Value of a Share|SLRN - Net Assets per Single Share|tffpharma.com (TFFP) - Net Assets per Single Share